title: [Therapy with immunoglobulins].
abstract: Adequate IgG-replacement therapy as treatment of choice for patients with humoral immunodeficiencies has revolutionized the outcome of these disorders. The action of intravenous immunoglobulins (IVIG) in autoimmune diseases, especially in idiopathic thrombocytic purpura seems to be due to Fc-receptor blockade and immunomodifying qualities. Thus far, treatment for patients with subclass deficiencies is restricted to persons with recurrent infections.
authors: Forschungsinstitut Borstel, Medizinische Klinik.
authors: E
authors: E
authors: Müller
authors: P
authors: P
authors: Zabel
mesh_terms: D001327:Autoimmune Diseases / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007275:Injections, Intravenous
chemical_list: D007074:Immunoglobulin G
vernacular_title: Therapie mit Immunglobulinen.